fluorescein-5-isothiocyanate has been researched along with Alzheimer Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, L; Li, K; Lin, J; Liu, Z; Wu, S; Ye, S; Zhu, S | 1 |
| Chamieh, J; Cottet, H; Deleanu, M; Hernandez, JF | 1 |
| Duncan, CJ; Gu, H; Jenkins, EC; Krinsky-McHale, SJ; Ni, SA; Pang, D; Schupf, N; Silverman, WP; Velinov, M; Ye, L; Zigman, WB | 1 |
| Chang, S; Ha, CM; Hong, HS; Kook, SY; Mook-Jung, I; Moon, M | 1 |
| Bilcer, G; Chang, WP; Da, H; Devasamudram, T; Downs, D; Ghosh, AK; Gordon, B; Koelsch, G; Tang, J; Weerasena, V; Wong, S | 1 |
| Bondareff, W; Harrington, C; Hauser, DL; Roth, M; Wischik, CM | 1 |
| Bondareff, W; Harrington, CR; Hauser, DL; Roth, M; Wischik, CM | 1 |
| Alford, MF; Hansen, LA; Masliah, E; Terry, RD | 1 |
| Mori, H; Sahara, N; Takano, T; Yamanouchi, Y | 1 |
| de Vos, NM; Eikelenboom, P; Nottet, HS; Raupp, SF; Smits, HA; Van Muiswinkel, FL; Verhoef, J | 1 |
| Cribbs, DH; Davies, TA; Eisenhauer, PB; Fine, RE; Hastey, R; Long, HJ; Simons, ER | 1 |
| Chang, P; Su, Y | 1 |
| Mori, O; Nagaoka, U; Nakamura, A; Uchihara, T; Yamazaki, M | 1 |
| Burbaeva, GSh; Kliushnik, TP; Vostriko, VM | 1 |
14 other study(ies) available for fluorescein-5-isothiocyanate and Alzheimer Disease
| Article | Year |
|---|---|
Excretion of Amyloid-β in the Gastrointestinal Tract and Regulation by the Gut Microbiota.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Fluorescein-5-isothiocyanate; Gastrointestinal Microbiome; Gastrointestinal Tract; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2022 |
Taylor dispersion analysis discloses the impairment of Aβ peptide aggregation by the presence of a fluorescent tag.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Peptide Fragments | 2023 |
Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Chromosome Aberrations; Cognition Disorders; Dementia; Down Syndrome; Female; Fluorescein-5-isothiocyanate; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Telomere | 2008 |
Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Biological Transport; Blood-Brain Barrier; Calcineurin; Calcium; Cell Line, Transformed; Claudins; Dextrans; Dipeptides; Disease Models, Animal; Endothelial Cells; Female; Fluorescein-5-isothiocyanate; Gene Expression Regulation; Glucose Transporter Type 1; Humans; Imaging, Three-Dimensional; Immunosuppressive Agents; Matrix Metalloproteinases; Membrane Proteins; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Microvessels; Mutation; Peptide Fragments; Phosphoproteins; Presenilin-1; Protease Inhibitors; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Tacrolimus; Tight Junctions; Transfection; Zonula Occludens-1 Protein | 2012 |
In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Blood-Brain Barrier; Brain; Cell Line; Cell Membrane; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Endopeptidases; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Humans; Injections, Intraperitoneal; Mice; Mice, Transgenic; Oligopeptides; Peptide Fragments; Peptides | 2004 |
Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease.
Topics: Alzheimer Disease; Antibodies; Epitopes; Fluorescein-5-isothiocyanate; Hippocampus; Humans; Immunohistochemistry; Microscopy; Nerve Degeneration; Neurofibrillary Tangles; Pronase; tau Proteins; Xanthenes | 1994 |
Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorescein-5-isothiocyanate; Humans; Immunohistochemistry; Male; Microscopy, Confocal; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 1995 |
A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain.
Topics: Aged; Alzheimer Disease; Antibodies, Monoclonal; Brain; Fluorescein-5-isothiocyanate; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Immunoblotting; Microscopy, Fluorescence; Synaptophysin | 1994 |
Assignment of Alzheimer's presenilin-2 (PS-2) gene to 1q42.1 by fluorescence in situ hybridization.
Topics: Alzheimer Disease; Chromosome Mapping; Chromosomes, Human, 1-3; Fluorescein-5-isothiocyanate; Genetic Linkage; Humans; In Situ Hybridization; Membrane Proteins; Microscopy, Fluorescence; Point Mutation; Presenilin-2 | 1997 |
The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Binding, Competitive; Brain Chemistry; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Luminescent Measurements; Macrophages; Monocytes; Peptide Fragments; Protein Binding; Respiratory Burst; Superoxides | 1999 |
Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Blood Platelets; Blood-Brain Barrier; Brain; Cells, Cultured; Endothelium, Vascular; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Male; Microscopy, Confocal; Middle Aged; Peptide Fragments; Platelet Activation; Protein Processing, Post-Translational | 2000 |
Protocol for quantitative and qualitative analyses of the in vitro aggregation of synthetic beta-amyloid. A method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biochemistry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Peptide Fragments; Spectrometry, Fluorescence | 2000 |
Dual enhancement of double immunofluorescent signals by CARD: participation of ubiquitin during formation of neurofibrillary tangles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibody Specificity; Biotin; Brain; Catalysis; Epitopes; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Microscopy, Confocal; Microscopy, Fluorescence; Neurofibrillary Tangles; tau Proteins; Tyramine; Ubiquitins | 2000 |
[Immunohistochemical detection of fibrous astrocytes using an antiserum to glial fibrillary acidic protein in the cerebral cortex in Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Astrocytes; Cerebral Cortex; Fibrosis; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Humans; Immune Sera; Immunohistochemistry; Middle Aged; Thiocyanates | 1988 |